Charles River Laboratories International Inc.

Charles River Laboratories International is a contract research organization engaged in laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. The company has three reportable segments: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment, which provides discovery and safety assessment services that include both in vivo and in vitro studies, supporting laboratory services, and non-clinical consulting and program management to support product development; and Manufacturing Support, which includes its microbial solutions, avian vaccine services and biologics testing solutions.
  • TickerCRL
  • ISINUS1598641074
  • ExchangeNew York Stock Exchange
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Charles River Laboratories Int'l, Inc. - March 2020 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Charles River Laboratories Int'l, Inc.: Update to credit analysis

Our credit view of Charles River reflecting its leading position as an early stage contract research organization, but strong appetite for M&A.

Charles River Laboratories International Inc: 2 directors gave away/sold/sold after exercising options

Two Directors at Charles River Laboratories International Inc gave away/sold/sold after exercising options 35,203 shares at between 0.000USD and 175.000USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Our outlook remains cautious and we continue to expect heightened volatility and a potential retest of the February 2018 lows over the next several weeks. Near-term we are monitoring for S&P 500 support near 2,600 (i.e., the October low) and resistance near 2,817 or the 100- and 50-day moving averages. In today's report we outline our current concerns along with developments that would cause us to become more constructive on the market. • Sector Relative Strength Rankings (RSRs) & Weighting Recommendations. We are upgrading Financials to market weight. A longstanding concern we have cited fo...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Property & Casualty Insurance names are staging price and RS reversal and/or breakouts. • A number of industrial manufacturing names are stabilizing and staging possible price and RS reversals. • Railroads related names are breaking out. A few truckers are also making positive inflections. A number of transports are highlighted in today's vital signs.

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • Biotechs continue to be leadership. We have highlighted a number of names in today's Vital Signs. • Many retail related names have pulled back to logical support. See today's Vital Signs for many of these stocks. • A number of Auto Component Suppliers and Homebuilders appear to be stabilizing. We did not highlight them in this report, but will continue to watch for reversals

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Upgrading Consumer Discretionary, downgrading Utilities; S&P 500 approaching potential resistance Sector Relative Strength Rankings. Stocks within retail and apparel Groups, long time favorites of ours, remain on a tear. Outperformance continued last week and allowed our equal-weighted Consumer Discretionary RSR to improve more than any other Sector. With both the XLY and our equal-weighted Sector breaking out to new price and relative strength highs, we are upgrading Consumer Discretionary to overweight. On the other hand, relative strength for Utilities is breaking below support to new mul...

Charles River Laboratories International Inc: 2 directors gave away/sold/sold after exercising options

Two Directors at Charles River Laboratories International Inc gave away/sold/sold after exercising options 35,203 shares at between 0.000USD and 175.000USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Dave Nicoski ...
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Key Resistance As we have outlined in recent weeks, our base case continues to be for near-term consolidation while the market is in a “wait-and-see” phase as it relates to states re-opening. The S&P 500 is again testing key resistance at the 61.8% Fibonacci retracement level of 2934.49 and also the 2950-3000 level we previously identified. We continue to have concerns that lead us to believe the market is not yet out of the woods, however these concerns are counterbalanced by a number of positive developments. When it comes down to it, key support levels mentioned last week i...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior